Free Biopharma Stock Content

What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that are expected to move a stock by at least 20% up or down. Big Mover™ events are typically a type of event with the highest chance of moving a stock (e.g. Phase 2, Phase 3, and PDUFA read-outs) given the importance of the clinical asset to the sponsor company. We call clinical events that appear likely to be Big Mover events Suspected Big Move

Our free Big-Mover Report : Listing of 10 of the biggest clinical readouts this quarter Use this info: To update your holdings before a readout To ID bullish or bearish trades before and/or thru readout Want more free clinical readouts this quarter? Click below: https://www.offers.bpiq.com/big-mover-lp Want even more info to help you find & analyze this quarters biggest movers, and big movers for future quarters? Sign up for ELITE (40% off) limited time offer: Suspected mov

We have gone through the Q2 2023 financial reports to analysis each companies product revenue to see: Q2 '23 revenue Q2 '22 revenue Q2 '23 / Q2 '22 Market cap multiple Approved products Already an Elite member? See the deeper article here! Q1 '23 vs. Q2 '23 revenue comparison Number of hedge funds that hold that company in Q2 '23 This article is NOT legal, investment or tax advice. Please do your own diligence before making any investments. Article history: 8/17/23 first pos

Last updated 8/15/23 Summary: Hedge fund holdings can help you discover new investment ideas Get more stock idea and see the full list of...

Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...

Big PDUFA from a big collaboration: BIIB & SAGE PDUFA - 8/5/23 - Zuranolone in MDD & PPD Collaboration since 2020… BIIB invested $1.5B in...

BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...

Consistent with top 36 biopharma hedge funds • Each held 22-125 companies @ end Q1 ⇒ Stonepine (22 companies) ⇒ EcoR1 (58) ⇒ RA Capital...

Overview: • Under the radar companies • Huge upside • Difficult FDA approval behind them ⇒ Typical for drug device combo ⇒ 2 CRLs • But...

PRTA tech validated by big BMS collaboration • BMS is part owner of PRTA BMS & PRTA collaboration highlights: 3/20/18 CELG & PRTA enter...

But, which is the best? • Some anti-beta amyloids (ABs) made it ⇒ thru pos Ph3 ⇒ 1 full FDA approval But lots of ABs have died in...

Summary: The Alzheimer's Association International Conference is taking place from July 16 - 20, 2023 Abstracts are embargoed until the...

Summary: BPIQ monitors M&A of smid-cap biopharmas There has been an uptick in biopharma M&A since May 2022 Q2 2023 started off with a...

Summary: BPIQ monitors M&A of smid-cap biopharmas There has been an uptick in biopharma M&A since May 2022 Q2 2023 started off with a...

Last updated 5/15/23 Summary: Hedge fund holdings can help you discover new investment ideas Get more stock idea and see the full list of...

Summary: The European Hematology Association Annual 2022 Meeting is taking place from June 8-11, 2023 EHA is an important event for...

First published 5/5/23 Summary: The American Society of Clinical Oncology Annual Meeting is taking place from June 2-6, 2023 The European...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Summary: BPIQ monitors M&A of smid-cap biopharmas There has been an uptick in biopharma M&A since May 2022 Q2 2023 started off with a...

Originally posted 5/3/2023; last updated 6/29/23 Summary: IPOs occur when private companies go public (offer shares to the public for the...